Number of the records: 1
Dexamethasone and betamethasone administration during pregnancy affects expression and function of 11beta-hydroxysteroid dehydrogenase type 2 in the rat placenta
- 1.
SYSNO ASEP 0329480 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Dexamethasone and betamethasone administration during pregnancy affects expression and function of 11beta-hydroxysteroid dehydrogenase type 2 in the rat placenta Title Podávání dexametasonu a betametasonu během těhotenství ovlivňuje expresi a funkci 11beta-hydroxysteroiddehydrogenasy v placentě potkana Author(s) Vacková, Z. (CZ)
Vagnerová, Karla (FGU-C) RID, ORCID
Libra, A. (CZ)
Mikšík, Ivan (FGU-C) RID, ORCID, SAI
Pácha, Jiří (FGU-C) RID, ORCID
Staud, F. (CZ)Source Title Reproductive Toxicology. - : Elsevier - ISSN 0890-6238
Roč. 28, č. 1 (2009), s. 46-51Number of pages 6 s. Language eng - English Country US - United States Keywords placenta ; syntetic glucocorticoids ; 11-betahydroxysteroid dehydrogenasa Subject RIV ED - Physiology R&D Projects KJB5011402 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR) CEZ AV0Z50110509 - FGU-C (2005-2011) UT WOS 000267198600007 DOI 10.1016/j.reprotox.2009.02.006 Annotation Placental barrier function mediated by 11-betahydroxysteroid dehydrogenase type 2, an enzyme that protects the fetus against abundance of maternal glucocorticoids, might be considerably impaired by the antenatal therapy with dexamethasone and betamethasone Workplace Institute of Physiology Contact Lucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400 Year of Publishing 2010
Number of the records: 1